Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 1 hour 3 min ago

Lead Edge Capital Announces $3.5 Billion for Fund VII

Mon, 03/23/2026 - 08:01
NEW YORK--(BUSINESS WIRE)--Lead Edge Capital, a leading growth equity firm investing in software, internet, and technology-enabled businesses, today announced the closing of Fund VII with $3.5 billion in commitments. The fund was oversubscribed and is the firm’s largest fund to date, bringing Lead Edge's total capital raised since inception to $9 billion. Lead Edge will target making private equity investments between $50 million to $400 million per portfolio company, targeting software, intern

Tracker Expands Recruitment Platform with Payroll Integrations and Additional Back-Office Capability

Mon, 03/23/2026 - 08:01
KNOXVILLE, Tenn.--(BUSINESS WIRE)-- #AI--Tracker has made a significant platform expansion, extending its industry-leading CRM and ATS with back-office operations and payroll integrations.

Venture Global Launches First Advertising Campaign: “Unstoppable Energy”

Mon, 03/23/2026 - 08:01
ARLINGTON, Va.--(BUSINESS WIRE)--Venture Global, Inc. is launching its first national advertising campaign – “Unstoppable Energy”.

The Hunt is Over! KRISPY KREME® is Filling Baskets with Egg-cellent New Easter Doughnuts

Mon, 03/23/2026 - 08:01
CHARLOTTE, N.C.--(BUSINESS WIRE)--Your hunt for the perfect Easter treats ends here! Krispy Kreme® is introducing a new Easter Basket Collection packed with playful, flavorful doughnuts you’ll want to grab fast — and share even faster. Available beginning Tuesday, March 24 for a limited time at participating Krispy Kreme shops across the U.S., Krispy Kreme’s Easter Basket Collection features three new, egg-citing doughnuts that bring spring sweetness to life: Easter Egg Basket Doughnut – an Ori

Oryon Cell Therapies Emerges From Stealth Focusing on Autologous Neuron Replacement Therapies for Parkinson’s Disease and Other Neurodegenerative Disorders

Mon, 03/23/2026 - 05:01
BELMONT, Mass.--(BUSINESS WIRE)--Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, today announced it has emerged from stealth and has closed a new $21 million tranche of its Series A financing, bringing its total funding in equity and grants to $42 million. Investors included Neuro.VC, Byers Capital, and others. The company's initial program is a neu

LTM Expands BlueVerse™ Tech with AppIQ, AgentIQ and FusionIQ to Accelerate AI‑Led Engineering

Mon, 03/23/2026 - 05:01
MUMBAI, India & WARREN, N.J.--(BUSINESS WIRE)---- $LTM #AI--LTM, today announced the expansion of BlueVerse™ Tech, its AI-led engineering platform, with the launch of AppIQ, AgentIQ and FusionIQ.

OpenObserve Expands Global Cloud Footprint in North America and Europe

Mon, 03/23/2026 - 05:01
SAN FRANCISCO--(BUSINESS WIRE)-- #B2B--OpenObserve, the high-performance observability platform built for petabyte-scale workloads, today announced a significant expansion of its global footprint. To meet the demands of enterprises requiring localized data residency and reduced latency, OpenObserve Cloud is now generally available in two new major regions: US West 2 (California) and EU-Central 1 (Frankfurt). Scaling with the Modern Enterprise OpenObserve is a cloud-native, unified observability platfo

Pages